Cargando…
Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia
Preeclampsia (PE) generally manifests in the second half of pregnancy with hypertension and proteinuria. The understanding of the origin and mechanism behind PE is incomplete, although there is clearly an immune component to this disorder. The placenta constitutes a complicated immune interface betw...
Autores principales: | Dijkstra, Douwe Jan, Lokki, A. Inkeri, Gierman, Lobke Marijn, Borggreven, Nicole Veronique, van der Keur, Carin, Eikmans, Michael, Gelderman, Kyra Andrea, Laivuori, Hannele, Iversen, Ann-Charlotte, van der Hoorn, Marie-Louise P., Trouw, Leendert Adrianus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009242/ https://www.ncbi.nlm.nih.gov/pubmed/35432365 http://dx.doi.org/10.3389/fimmu.2022.842451 |
Ejemplares similares
-
MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023) -
The Immunogenetic Conundrum of Preeclampsia
por: Lokki, A. Inkeri, et al.
Publicado: (2018) -
Genetic Analysis of Membrane Cofactor Protein (CD46) of the Complement System in Women with and without Preeclamptic Pregnancies
por: Lokki, A. Inkeri, et al.
Publicado: (2015) -
Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study
por: de Vos, Thijs W., et al.
Publicado: (2021) -
Complement Activation and Regulation in Preeclamptic Placenta
por: Lokki, Anna Inkeri, et al.
Publicado: (2014)